Table of Content


Chapter 1. Global Small Molecule Targeted Cancer Therapy Market Executive Summary
1.1. Global Small Molecule Targeted Cancer Therapy Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Type
1.3.2. By Monoclonal Antibodies
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Small Molecule Targeted Cancer Therapy Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Biomarker-Driven Treatment Regimens
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Small Molecule Targeted Cancer Therapy Market Dynamics
3.1. Market Drivers
3.1.1. Rising Global Cancer Incidence
3.1.2. Unmet Need for Effective and Less Toxic Therapies
3.1.3. Advances in High-Throughput Screening Technologies
3.2. Market Challenges
3.2.1. High Development Costs and Regulatory Complexity
3.2.2. Tumor Heterogeneity and Acquired Resistance Mechanisms
3.2.3. Access Disparities and Pricing Concerns
3.3. Market Opportunities
3.3.1. Growth of Small Molecule Drug Conjugates
3.3.2. Surge in Companion Diagnostics and Patient Stratification
3.3.3. Synergistic Combination Therapies of Small Molecules and Monoclonal Antibodies
Chapter 4. Global Small Molecule Targeted Cancer Therapy Market Industry Analysis
4.1. Porter’s Five Forces Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s Five Forces Model
4.1.7. Porter’s Five Forces Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economic
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunity
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Small Molecule Targeted Cancer Therapy Market Size & Forecasts by Type (2022-2032)
5.1. Segment Dashboard
5.2. Global Market: Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Small Molecule Drug Conjugates
5.2.2. Small Molecule Cyclin-Dependent Kinase Inhibitor
5.2.3. Small Molecule Proteasome Inhibitor
5.2.4. Small Molecule Tyrosine Kinase Inhibitor
Chapter 6. Global Small Molecule Targeted Cancer Therapy Market Size & Forecasts by Monoclonal Antibody Type (2022-2032)
6.1. Segment Dashboard
6.2. Global Market: Monoclonal Antibody Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Fully Human Monoclonal Antibody
6.2.2. Chimeric Monoclonal Antibody
6.2.3. Humanized Monoclonal Antibody
Chapter 7. Global Small Molecule Targeted Cancer Therapy Market Size & Forecasts by Region (2022-2032)
7.1. North America Market
7.1.1. U.S. Market
7.1.1.1. Type Breakdown Size & Forecasts, 2022-2032
7.1.1.2. Monoclonal Antibody Type Breakdown Size & Forecasts, 2022-2032
7.1.2. Canada Market
7.2. Europe Market
7.2.1. U.K. Market
7.2.2. Germany Market
7.2.3. France Market
7.2.4. Spain Market
7.2.5. Italy Market
7.2.6. Rest of Europe Market
7.3. Asia Pacific Market
7.3.1. China Market
7.3.2. India Market
7.3.3. Japan Market
7.3.4. Australia Market
7.3.5. South Korea Market
7.3.6. Rest of Asia Pacific Market
7.4. Latin America Market
7.4.1. Brazil Market
7.4.2. Mexico Market
7.4.3. Rest of Latin America Market
7.5. Middle East & Africa Market
7.5.1. Saudi Arabia Market
7.5.2. South Africa Market
7.5.3. Rest of Middle East & Africa Market
Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.1.1. Pfizer Inc.
8.1.2. Novartis AG
8.1.3. Bristol-Myers Squibb Company
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Pfizer Inc.
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Market Strategies
8.3.2. Novartis AG
8.3.3. Bristol-Myers Squibb Company
8.3.4. AstraZeneca plc
8.3.5. F. Hoffmann-La Roche Ltd
8.3.6. Amgen Inc.
8.3.7. Eli Lilly and Company
8.3.8. Merck & Co., Inc.
8.3.9. AbbVie Inc.
8.3.10. Johnson & Johnson
8.3.11. Bayer AG
8.3.12. Takeda Pharmaceutical Company Limited
8.3.13. Daiichi Sankyo Company, Limited
8.3.14. Exelixis, Inc.
8.3.15. Seagen Inc.
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes



List of Figures

List of Figures
FIG 1. Global market, research methodology
FIG 2. Global market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global market, key trends 2023
FIG 5. Global market, growth prospects 2022-2032
FIG 6. Global market, Porter’s Five Forces Model
FIG 7. Global market, PESTEL analysis
FIG 8. Global market, value chain analysis
FIG 9. Global market by segment, 2022 & 2032 (USD Billion)
FIG 10. Global market by segment, 2022 & 2032 (USD Billion)
FIG 11. Global market by segment, 2022 & 2032 (USD Billion)
FIG 12. Global market by segment, 2022 & 2032 (USD Billion)
FIG 13. Global market by segment, 2022 & 2032 (USD Billion)
FIG 14. Global market, regional snapshot 2022 & 2032
FIG 15. North America market 2022 & 2032 (USD Billion)
FIG 16. Europe market 2022 & 2032 (USD Billion)
FIG 17. Asia Pacific market 2022 & 2032 (USD Billion)
FIG 18. Latin America market 2022 & 2032 (USD Billion)
FIG 19. Middle East & Africa market 2022 & 2032 (USD Billion)
FIG 20. Global market, company market share analysis (2023)

List of Tables

List of Tables
TABLE 1. Global Small Molecule Targeted Cancer Therapy market, report scope
TABLE 2. Global market estimates & forecasts by Region 2022-2032 (USD Billion)
TABLE 3. Global market estimates & forecasts by Type 2022-2032 (USD Billion)
TABLE 4. Global market estimates & forecasts by Monoclonal Antibody Type 2022-2032 (USD Billion)
TABLE 5. Global market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 6. Global market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 7. U.S. market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 8. U.S. market estimates & forecasts by Type, 2022-2032 (USD Billion)
TABLE 9. U.S. market estimates & forecasts by Monoclonal Antibody Type, 2022-2032 (USD Billion)
TABLE 10. Canada market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 11. Canada market estimates & forecasts by segment, 2022-2032 (USD Billion)
TABLE 12. Europe market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 13. Asia Pacific market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 14. Latin America market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 15. Middle East & Africa market estimates & forecasts, 2022-2032 (USD Billion)